MS (Multiple Sclerosis) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting ms (multiple sclerosis) clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Abu Dhabi, United Arab Emirates, Beijing, Beijing Municipality, China, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


MS (Multiple Sclerosis) Trials at a Glance

7 actively recruiting trials for ms (multiple sclerosis) are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Abu Dhabi, Beijing, and Copenhagen. Lead sponsors running ms (multiple sclerosis) studies include Inonu University, Sheikh Shakhbout Medical City, and Daphne Kos.

Browse ms (multiple sclerosis) trials by phase

Treatments under study

About MS (Multiple Sclerosis) Clinical Trials

Looking for clinical trials for MS (Multiple Sclerosis)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MS (Multiple Sclerosis) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MS (Multiple Sclerosis) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Psilocybin Therapy for Psychological Distress in Palliative Patients

COPD, Chronic Obstructive Pulmonary DiseaseMajor Depressive Disorder (MDD)ALS (Amyotrophic Lateral Sclerosis)+2 more
University Medical Center Groningen108 enrolled4 locationsNCT06782724
Recruiting
Not Applicable

At Home Use of Stimulation Suits for Managing MS Symptoms

Multiple SclerosisSpasticityAtaxia - Other+5 more
Daphne Kos70 enrolled2 locationsNCT07202195
Recruiting

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Multiple SclerosisMS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remitting+3 more
University of California, San Francisco300 enrolled1 locationNCT07222618
Recruiting
Not Applicable

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

Acute Disseminated EncephalomyelitisMS (Multiple Sclerosis)Transcranial Alternating Current Stimulation+2 more
Xuanwu Hospital, Beijing128 enrolled1 locationNCT07087873
Recruiting
Phase 1

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

Alzheimer's Disease(AD)MCIDemyelinating Disorders+3 more
Yale University105 enrolled1 locationNCT06999434
Recruiting

Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis

MS (Multiple Sclerosis)
Inonu University33 enrolled1 locationNCT06849882
Recruiting
Not Applicable

EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2)

Sclerosis, MultipleMS (Multiple Sclerosis)Spasticity, Muscle+1 more
Sheikh Shakhbout Medical City36 enrolled1 locationNCT05857280